(b)(4).During processing of this complaint, attempts were made to obtain complete event, patient and device information.The device was not returned for evaluation.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot.The reported patient effect of cardiac perforation (atrial perforation), as listed in the mitraclip system instructions for use, is a known possible complication associated with mitraclip procedures.Based on the information reviewed, the reported patient effect of atrial perforation appears to be related to patient morphology/pathology due to the floppy septum and there is no indication of a product quality issue with respect to manufacture, design or labeling.
|
This is filed to report the torn septum.It was reported that on (b)(6) 2016 one mitraclip was implanted in the patient with degenerative mitral regurgitation (mr) reducing mr from grade 4 to 1.On (b)(6) 2017 a second mitraclip procedure was performed for recurrent mr grade 4+.The original mitraclip was stable and attached to both leaflets.At the re-clip procedure, during insertion of the steerable guide catheter (sgc) through the fossa ovalis of the floppy septum, the fossa ovalis became torn resulting in inadequate support of the sgc.There was difficulty steering to the valve because of the torn septum, but there were no device issues and one mitraclip was successfully implanted, reducing mr was reduced to grade 2+.There was no additional information provided.
|